Telemonitoring of Chronic Wound Patients Using MyDerm, a Digital Solution: Feasibility Study
Launched by PIXACARE · Nov 21, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Telemonitoring of Chronic Wound Patients Using MyDerm" is exploring how well a digital solution called MyDerm can help monitor and manage chronic wounds on the lower limbs. This study is aimed at patients over 18 years old who have a single chronic wound that has been present for more than six weeks. The researchers want to see if using MyDerm, which allows patients to take photos of their wounds and answer simple questionnaires, can improve care and satisfaction for both patients and caregivers.
To participate, individuals must meet specific criteria, such as having a chronic wound on their lower limb and being able to use a smartphone with an internet connection. Participants will use the MyDerm solution for two months and then answer questions about their experience, which will help researchers understand its effectiveness. The study is not yet recruiting participants, but it focuses on how well remote monitoring can fit into everyday healthcare practices and how it impacts patients based on their age, gender, and education level.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with a single chronic wound of the lower limb (more than 6 weeks)
- • Benefiting from the MyDerm digital wound-healing monitoring solution
- • Patient aged 18 or over
- • Informed patient who has not objected to the use of data
- Exclusion Criteria:
- • Patient refusing to participate in the study
- • Patient included in a clinical trial
- • Patient with a life expectancy shorter than the duration of the study
- • Patient with cognitive impairment
- • Inability to install or use the medical device for technical reasons (lack of internet connection, lack of 4G coverage or more, lack of smartphone)
- • Patient requiring home hospital care
- • Patient requiring Follow-up and rehabilitation care
- • Pregnant or breast-feeding women
- • Patient with a previously infected wound
About Pixacare
Pixacare is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on delivering cutting-edge therapies, Pixacare collaborates with healthcare professionals and institutions to conduct rigorous clinical trials that prioritize patient safety and efficacy. The organization is committed to transparency and ethical practices, ensuring that all studies are designed and executed to meet the highest regulatory standards. By leveraging advanced technologies and methodologies, Pixacare aims to accelerate the path from discovery to market, ultimately improving patient outcomes and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Corbeil Essonnes, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported